As a result of reduced levels of carnitine, levels of all acyl-carnitines were also reduced in the clinical brain tumor samples with IDH mutation (Fig. 4C), although fatty acid levels in IDH mutant samples were similar to those in normal IDH tumor samples (Fig. 4D). The gene discussed is IDH2; the disease is neoplasm.